Treatment Perception of QD Dosed Kaletra (Tablets) Based Treatment in HIV Infected Patients. Observational Cross-Sectional Study (QD-KAPITAL)
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2013
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms QD-KAPITAL
- Sponsors Abbott Laboratories
- 20 Feb 2012 Actual patient number (197) added as reported by ClinicalTrials.gov.
- 20 Feb 2012 Actual end date (December 2011) added as reported by ClinicalTrials.gov.
- 20 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.